Jyong Biotech Ltd.
Develops plant-derived drugs for urinary system diseases, with a drug in Phase III.
MENS | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 23F-3, NO.95, SEC. 1, XINTAI 5TH RD., 221 NEW TAIPEI CITY
- Website:
- https://jyongbio.com/
- Sector:
- Manufacturing
Description
Jyong Biotech Ltd. is a science-driven biotechnology company focused on the development and commercialization of plant-derived drugs for urinary system diseases. The company's primary therapeutic areas include benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Its lead drug candidate, MCS-2, is a botanical formulation that has completed late-stage (Phase III) clinical trials. Leveraging a proprietary research and development platform, Jyong Biotech aims to advance its pipeline of innovative botanical medicines to address unmet medical needs in urology for a global patient population.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Jyong Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Jyong Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Jyong Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
